Walleye Trading LLC Altimmune, Inc. Call Options Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$8.22 - $13.81 $8,220 - $13,810	1,000 Added 1000.0%	1,100 $11,000
Q1 2023 May 15, 2023	SELL	$4.19 - $16.83 $7,542 - $30,293	-1,800 Reduced 94.74%	100 $0
Q4 2022 Feb 14, 2023	BUY	$8.74 - $16.45 $16,606 - $31,255	1,900 New	1,900 $31,000
Q2 2022 Aug 08, 2022	BUY	$3.94 - $11.77 $394 - $1,177	100 New	100 $1,000
Q1 2022 May 16, 2022	SELL	$5.9 - $9.45 $128,030 - $205,064	-21,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $188,573 - $270,816	21,700 New	21,700 $199,000

186

39.3M

913K

743K

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $358M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.